Hepatocellular carcinoma recurrence occurs in 40–70% of patients after hepatic resection.
Despite the high frequency of hepatocellular cancer relapse, there is no established …

Background Intrahepatic recurrence of hepatocellular carcinoma (HCC) following resection
is common. However, no current consensus guidelines exist to inform management …

Background & Aims Few studies have been conducted to compare the efficacies of
stereotactic body radiation therapy (SBRT) and radiofrequency ablation (RFA). Thus, in this …

Importance Repeat hepatectomy and percutaneous radiofrequency ablation (PRFA) are
most commonly used to treat early-stage recurrent hepatocellular carcinoma (RHCC) after …

Objective: To evaluate the long-term outcomes of surgery for recurrent hepatocellular
carcinoma (HCC). Background: HCC recurs with high incidence after liver resection. Little is …

Background The optimal local treatment for HCC with tumor diameter≥ 5 cm is not well
established. This research evaluated the effectiveness of external beam radiation therapy …

Background and purpose To evaluate the efficacy of stereotactic body radiotherapy (SBRT)
and radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). Methods and …

Tumor ablation is broadly defined as the destruction of focal tumors by direct application of
chemicals or energy. 1 Tumor ablation therapies are delivered via needlelike applicators …

Background Hepatocellular carcinoma (HCC) has a high rate of recurrence. This network
meta-analysis aimed to compare the oncological prognosis of the conventional treatments …

Background The therapeutic value of repeat hepatic resection (rHR) or radiofrequency
ablation (RFA) for recurrent hepatocellular carcinoma (HCC) is unknown. This study aimed …